Afuco™ Anti-EGFR ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H49) (CAT#: AFC-TAB-H49)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant Chimeric antibody to Human EGFR.

Specific Inquiry
  • Size:

  • Conjugation:

  • Endotoxin:

  • Purity:

  • Formats:

  • Isotype Switching:

  • Fc Engineering:

  • Modalities:

Custom Production

We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

Sequences:
Isotype :
Purity :
Endotoxin :
Quantity :
Conjugation :
Fc Engineering :
Modalities :
Other Requirements:
We require custom production
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Chimeric
  • Derivation
  • Chimeric
  • Type
  • ADCC enhanced antibody
  • Specificity
  • EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB) [Homo sapiens]
  • Species Reactivity
  • Human
  • Applications
  • FuncS, IF, Neut, ELISA, FC, IP
  • Conjugate
  • Unconjugated
  • Generic Name
  • Modotuximab
  • Related Disease
  • Colorectal cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • EGFR; epidermal growth factor receptor; epidermal growth factor receptor (avian erythroblastic leukemia viral (v erb b) oncogene homolog), ERBB; ERBB1; erythroblastic leukemia viral (v erb b) oncogene homolog (avian); proto-oncogene c-ErbB-1;

Related Resources

  • Biosimilar Overview
  • Related Diseases
  • Related Signaling Pathways
Please refer to Modotuximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Modotuximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "modotuximab"

Anti-Human EGFR Recombinant Antibody (Modotuximab)
Recombinant Chimeric antibody to Human EGFR

See other products for "EGFR"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibodies Human Antibodies Chimeric Antibodies IgG Antibodies Fab Antibodies Mouse Antibodies Fc Glycosylation Antibodies High-mannose Glycoform Antibodies Deglycosylated Antibodies Chicken IgY Antibodies MHC Tetramers for Cancer Neutralizing Antibodies Rabbit Monoclonal Antibodies ScFv Antibodies ADCC Enhanced Antibodies Single Domain Antibodies Antibody Magnetic Beads Cancer Stem Cell Biomarker Specific Antibodies NHP Antibodies ScFv-Fc Chimeras FC Reagents & Kits IHC Kits & Antibodies Extracellular Vesicle Antibodies Biparatopic Antibodies

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-H49. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare